IP Verse

Rapamycin Derivative For Treating Advanced Solid Tumours

Patent No. EP3345602 (titled "Rapamycin Derivative For Treating Advanced Solid Tumours") was filed by Novartis on Feb 18, 2002. The application was issued on Apr 6, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHYPHARMJan 6, 2023LLR
GENERICS UKJan 6, 2023ELKINGTON AND FIFE
STADA ARZNEIMITTELJan 4, 2023HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3345602

NOVARTIS
Application Number
EP18155722A
Filing Date
Feb 18, 2002
Status
Granted And Under Opposition
Mar 4, 2022
Publication Date
Apr 6, 2022
External Links
Slate, Register , Google Patents